Xencor | Lucro Bruto Sobre Vendas



Gross Profit On Sales Alterar Data
AbbVie USD 9.34B 1.36B 2025-03
Alnylam Pharmaceuticals USD 630.74M 107.59M 2025-06
Amgen USD 6.17B 624M 2025-06
Arrowhead Research 27.77M 514.94M 2025-06
AstraZeneca USD 11.98B 637M 2025-06
Biogen USD 2.04B 238.8M 2025-06
Bristol-Myers Squibb USD 8.9B 714M 2025-06
Cytokinetics 66.77M 165.03M 2025-06
GlaxoSmithKline GBP 5.82B 229M 2025-06
J&J USD 14.6B 816M 2025-03
MacroGenics USD 13.86M 94.98M 2024-12
Merck USD 12.99B 224M 2025-06
Novartis USD 11.51B 1.12B 2025-06
Pfizer USD 10.88B 248M 2025-06
Regeneron Pharmaceuticals USD 3.15B 581M 2025-06
Roche Holding CHF 11.69B 48M 2024-12
Xencor 43.61M 10.88M 2025-06


Xencor Lucro Bruto Sobre Vendas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.